Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Enrolled patients had a baseline or recent liver biopsy showing clinically significant MASLD (metabolic dysfunction-associated steatotic liver disease), defined as MASH with fibrosis stage 2 or 3 and a non-alcoholic fatty liver disease (NAFLD) Activity Score (NAS) 4 with a score of 1 or more in steatosis, lobular inflammation, and hepatocyte ballooning
In der Schweiz so gut wie unmglich oder sehr teuer und als Privatperson nicht mglich
If left untreated, these changes can progress to liver fibrosis, cirrhosis, and ultimately liver failure
Theyre designed to be mixed with water and be consumed at any time
There are no patient assistance programs or savings cards like those offered by Novo Nordisk for Wegovy
